Browse > Article

Effect of Thesium Chinense Turczaninow on Breast Cancer Chemopreventive enzyme activity in In vitro  

Shon, Yun-Hee (Intractable Diseases Research Center, College of Medicine, Dongguk University)
Kim, Mee-Kyung (Intractable Diseases Research Center, College of Medicine, Dongguk University)
Park, Sun-Dong (Cardiovascular Medical Research Center and Department of Pharmacology, College of Medicine, Dongguk University)
Nam, Kyung-Soo (Cardiovascular Medical Research Center and Department of Pharmacology, College of Medicine, Dongguk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.20, no.3, 2006 , pp. 675-679 More about this Journal
Abstract
The effect of water extract from Thesium chinese Turczaninow (TCTW) on proliferation of human breast cancer cells, nitric oxide production, nitric oxide synthase expression, and ornithine decarboxylase activity was tested. TCTW inhibited the growth of both estrogen-independent MDA-MB-231 and estrogen-dependent MCF-7 human breast cancer cells. Lipopolysaccharide-induced nitric oxide (NO) production was significantly reduced by TCTW at the concentrations of 1.0 (p<0.05) and 5.0 mg/ml (p<0.005). Expression of inducible nitric oxide synthase (iNOS) was also suppressed with the treatment of TCTW in Western blot analysis. TCTW inhibited induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate (TPA), a key enzyme of polyamine biosynthesis, which is enhanced in tumor promotion. Therefore, TCTW is worth further investigation with respect to breast cancer chernoprevention or therapy.
Keywords
Thesium chinense Turczannow; nitric oxide; nitric oxide synthase; ornithine decarboxylase; breast cancer; chernoprevention;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ries, L., Wingo, P.A., Miller, S.S., Howe, H., Weir, H.K., Rosenberg, H.M., Vernon, S.W., Cronin, K., Edwards, B.K. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88, 2398-2424, 2000   DOI   ScienceOn
2 Fisher, B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmaik, N. other National Surgical Adjuvant Breast and Bowel Project Investigators. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 18, 1371-1388, 1998
3 Knowles, R.G., Moncada, S. Nitric oxide synthases in mammals. Biochem. J. 298, 249-258, 1994   DOI
4 Wink, D.A., Hanbauer, I., Grisham, M.B., Laval, F., Nims, R.W., Laval, J., Cook, J., Pacelli, R., Liebmann, J., Krishna, M., Ford, P.C., Mitchell, J.B. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top. Cell Regul. 34, 159-187, 1996   DOI
5 Green, J.E., Shibata, M.A., Shibata, E., Moon, R.C., Anver, M.R., Kelloff, G., Lubet, R. 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Res. 61, 7449-7455, 2001
6 Glikman, P., Vegh, J., Pollina, M.A., Mosto, A.H., Levy, C.M. Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer (Phila) 60, 2237-2243, 1987   DOI   ScienceOn
7 Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G., Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41-44, 1995   DOI   ScienceOn
8 Vakkala, M., Kahlos, K., Lakari, E., Paakko, P., Kinnula, V., Soini, Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in situ and invasive breast carcinomas. Clin. Cancer Res. 6, 2408-2416, 2000
9 Suh, N., Glasebrook, A.L., Palkowitz, A.D., Bryant, H.U., Burris, L.L., Starling, J.J., Pearce, H.L., Williams, C., Peer, C., Wang Y., Sporn, M.B. Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. Cancer Res. 61, 8412-8415, 2001
10 Tamir, S., Tannenbaum, S.R. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta. 1288, F31-F36, 1996
11 Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Felley-Bosco, E., Hussain, S.P., Harris, C.C. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst. 91, 86-88, 1999   DOI   ScienceOn
12 Tschugguel, W., Knogler, W., Czerwenka, K., Mildner, M., Weninger, W., Zeillinger, R., Huber, J.C. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br. J. Cancer 74, 1423-1426, 1996   DOI   ScienceOn
13 康秉秀. 本草學, 永林社, 서울, p 169, 1991
14 Kroncke, K.D., Fehsel, K., Suschek, C., Kolb-Bachofen, V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol. 1, 1407-1420, 2001   DOI   ScienceOn
15 Huber, M., Poulin, R. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth. J. Clin. Endocrinol. Metab. 81, 113-123, 1996   DOI
16 김동일. 鄕藥集成方, 여강출판사, 서울, p 152, 1991
17 Li, L., Carol, T., Susan, K.G. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverse spontaneous tumors in ODC/Ras transgenic mice. Cancer Res. 60, 5696-5730, 2000
18 Robbins, R.A., Barnes, P.J., Springall, D.R., Warren, J.B., Kwon, O.J., Buttery, L.D., Wilson, A.J., Geller, D.A., Polak, J.M. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Comm. 203, 209-218, 1994   DOI   ScienceOn
19 Ambs, S., Hussain, S.P., Harris, C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11, 443-448, 1997   DOI
20 Macchiarini, P., Fontanini, G., Hardin, M.J., Squartini, F., Angeletti, C.A. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340, 145-146, 1992   DOI   ScienceOn
21 Manni, A., Astrow, S.H., Gammon, S., Thompson, J., Mauger, D., Washington, S. Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens. Breast Cancer Res. Treat. 67, 147-156, 2001   DOI   ScienceOn
22 Marton, L.J., Pegg, A.E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35, 55-91, 1995   DOI   ScienceOn